Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally
Source: SeekingAlpha
2025-08-12 12:46:31 ET
...
Read the full article on Seeking Alpha
For further details see:
Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally
Emergent Biosolutions Inc.
NASDAQ: EBS
EBS Trading
-2.77% G/L:
$8.07 Last:
274,373 Volume:
$8.03 Open:
EBS Latest News
March 03, 2026 08:00:00 am
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors
February 26, 2026 04:05:00 pm
Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026 04:01:00 pm
Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada, Strengthening Canada's Leadership in Health Preparedness
February 26, 2026 04:01:00 pm
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program
EBS Stock Data
$592,950,394
50,839,325
1.42%
58
N/A
Pharmaceuticals
Healthcare
US
Gaithersburg
